XML 18 R7.htm IDEA: XBRL DOCUMENT v3.21.2
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
9 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Cash flows from operating activities:    
Net loss $ (4,495,064) $ (2,813,932)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation 868 639
Stock-based compensation 836,456 116,872
Changes in operating assets and liabilities:    
Prepaid expenses and other current assets (1,128,933) (19,418)
Accounts payable and other current liabilities (2,964,147) 348,241
Net cash used in operating activities (7,750,820) (2,367,598)
Cash flows from investing activities:    
Purchases of property and equipment (3,854)
Net cash used in investing activities (3,854)
Cash flows from financing activities:    
Proceeds from merger 16,346,622
Decoy’s transaction costs (665,627)
Issuance of pre-funded warrants and warrants 29,972,727
Issuance costs of Private Placement (2,706,598)
Exercise of pre-funded warrants 27,273
Proceeds from SAFEs 5,000,000 1,167,129
Net cash provided by financing activities 47,974,397 1,167,129
Net increase (decrease) in cash and cash equivalents 40,219,723 (1,200,469)
Cash and cash equivalents at beginning of period 1,637,499 3,798,955
Cash and cash equivalents at end of period 41,857,222 2,598,486
Noncash investing and financing activities    
Conversion of preferred stock 8,359
Conversion of SAFEs 6,417,129
Liabilities assumed, net of non-cash assets received in reverse merger 7,616,175
Release of deposit upon closing of Merger 200,000
Supplemental cash flow disclosures    
Cash paid for income taxes 800 800
Cash received for interest earned on deposits $ 2,362 $ 12,365